Your browser doesn't support javascript.
loading
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
Morath, Christian; Schmitt, Anita; Schmitt, Michael; Wang, Lei; Kleist, Christian; Opelz, Gerhard; Süsal, Caner; Tran, T Hien; Scherer, Sabine; Schwenger, Vedat; Kemmner, Stephan; Fischereder, Michael; Stangl, Manfred; Hauser, Ingeborg A; Sommerer, Claudia; Nusshag, Christian; Kälble, Florian; Speer, Claudius; Benning, Louise; Bischofs, Christian; Sauer, Sandra; Schubert, Maria-Luisa; Kunz, Alexander; Hückelhoven-Krauss, Angela; Neuber, Brigitte; Mehrabi, Arianeb; Schwab, Constantin; Waldherr, Rüdiger; Sander, Anja; Büsch, Christopher; Czock, David; Böhmig, Georg A; Reiser, Jochen; Roers, Axel; Müller-Tidow, Carsten; Terness, Peter; Zeier, Martin; Daniel, Volker; Schaier, Matthias.
Afiliación
  • Morath C; TolerogenixX GmbH, Heidelberg, Germany christian.morath@med.uni-heidelberg.de.
  • Schmitt A; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schmitt M; German Center for Infection Research, DZIF, TTU-IICH, Partner site Heidelberg, Heidelberg, Germany.
  • Wang L; TolerogenixX GmbH, Heidelberg, Germany.
  • Kleist C; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Opelz G; TolerogenixX GmbH, Heidelberg, Germany.
  • Süsal C; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Tran TH; TolerogenixX GmbH, Heidelberg, Germany.
  • Scherer S; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schwenger V; TolerogenixX GmbH, Heidelberg, Germany.
  • Kemmner S; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Fischereder M; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Stangl M; TolerogenixX GmbH, Heidelberg, Germany.
  • Hauser IA; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sommerer C; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Nusshag C; Transplant Immunology Research Center of Excellence, Koç University, Istanbul, Turkey.
  • Kälble F; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Speer C; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Benning L; Department of Nephrology, Transplant Center, Klinikum der Landeshauptstadt Stuttgart, Stuttgart, Germany.
  • Bischofs C; Transplant Center, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
  • Sauer S; Division of Nephrology, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
  • Schubert ML; Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
  • Kunz A; Department of Nephrology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Hückelhoven-Krauss A; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Neuber B; German Center for Infection Research, DZIF, TTU-IICH, Partner site Heidelberg, Heidelberg, Germany.
  • Mehrabi A; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schwab C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Waldherr R; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sander A; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Büsch C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Czock D; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Böhmig GA; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Reiser J; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Roers A; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Terness P; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Zeier M; Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Daniel V; Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schaier M; Institut of Medical Biometry, Heidelberg University Hospital, Heidelberg, Germany.
BMJ Open ; 12(11): e066128, 2022 11 11.
Article en En | MEDLINE | ID: mdl-36368749
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article